联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03933 联邦制药

已收盘 03-23 16:08:09

10.100

-0.380

-3.63%

最高10.310	最低9.910	成交量1,339万
今开10.290	昨收10.480	日振幅3.82%
总市值199.27亿	流通市值199.27亿	总股本19.73亿
成交额1.34亿	换手率0.68%	流通股本19.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"联邦制药","latestPrice":10.1,"timestamp":1774253289007,"preClose":10.48,"halted":0,"volume":13387900,"delay":0,"changeRate":-0.0362595419847329,"floatShares":1973000000,"shares":1973000000,"eps":1.463938,"marketStatus":"已收盘","change":-0.38,"latestTime":"03-23 16:08:09","open":10.29,"high":10.31,"low":9.91,"amount":134346428,"amplitude":0.038168,"askPrice":10.1,"askSize":80000,"bidPrice":10.08,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":1.702,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":5,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":10.48,"dividendRate":0.048717,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":0.961115,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","LU2399975544.HKD","02367","LU0540923850.HKD","LU1303224171.USD","LU2476274720.SGD","01530","LU0634319403.HKD","LU1115378108.SGD","BK1197","06160","LU0348827113.USD","IE00BPRC5H50.USD","LU1719994722.HKD","IE00B543WZ88.USD","BK1161","LU0348766576.USD","LU0348767384.USD","LU2476274308.USD","LU2488822045.USD","BK1585","BK1588","09926","BK1593","LU1794554557.SGD","BK1583","BK1141","02196","01099","BK1574","LU2778985437.USD","03933","09688","BK1500","BK1191","LU1770034418.SGD","LU0348735423.USD","06821","BK1617","03329","LU2328871848.SGD","LU0417516571.SGD","02228","BK1207","LU0307460666.USD","LU0348784397.USD","LU0417516738.SGD","02268","LU0417516902.SGD","CXO"],"gpt_icon":0},{"id":"1186668475","title":"一周港股牛熊榜 | 健康160 正式获纳入港股通名单吸引北水参与，一周升逾94%；迅策、中国旭阳集团升近50%强势爆发；联邦制药因盈利预警跌近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186668475","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186668475?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:45","pubTimestamp":1773391539,"startTime":"0","endTime":"0","summary":"此外，公司被调入港股通后吸引北水参与，市场买盘强劲，连续上涨。2025年7月推出的IAP ROAS优化策略成功切入中重度游戏市场，曝光占比从5.54%迅速提升至18.24%。核心业务中间体及原料药因市场价格下跌，导致分部溢利大幅下降。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01384","02617","02665","01907","02889","02656","01860","03933","03317","02661"],"gpt_icon":1},{"id":"2619579111","title":"联邦制药盘中异动 急速下挫7.61%报11.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619579111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619579111?lang=zh_cn&edition=full","pubTime":"2026-03-13 09:30","pubTimestamp":1773365405,"startTime":"0","endTime":"0","summary":"2026年03月13日早盘09时30分，联邦制药股票出现异动，股价急速跳水7.61%。截至发稿，该股报11.900港元/股，成交量45.2万股，换手率0.02%，振幅2.48%。资金方面，该股资金流入16.938万港元，流出105.602万港元。联邦制药股票所在的药品行业中，整体涨幅为0.25%。其相关个股中，四环医药、康臣药业、东阳光药涨幅较大，振幅较大的相关个股有联邦制药、康龙化成、长风药业，振幅分别为2.48%、1.59%、1.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313093005a465351b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313093005a465351b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"1196280784","title":"联邦制药2025年业绩承压：中间体业务利润锐减16亿元，原料药板块下滑4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196280784","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196280784?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:12","pubTimestamp":1773310359,"startTime":"0","endTime":"0","summary":"联邦制药国际控股有限公司（股份代码：03933）2025年财务数据显示，公司核心业务板块出现显著利润收缩。其中，中间体产品分部利润同比大幅减少约16亿元人民币；同期，原料药（大宗药品）业务利润亦下滑4亿元。\n此番利润下滑凸显出公司在关键业务领域面临的经营压力。中间体产品作为医药制造的重要环节，其利润大幅收窄可能受到上游原材料成本上升及市场竞争加剧的双重影响。而原料药业务的利润收缩，则反映出全球医药市场格局变动及价格波动对该公司造成的冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1106597435","title":"联邦制药国际：中间体及原料药市场价格下跌或致全年业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106597435","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106597435?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:08","pubTimestamp":1773310091,"startTime":"0","endTime":"0","summary":"联邦制药国际（United Laboratories International）表示，由于中间体及大宗原料药市场价格出现下滑，公司预计本财年整体业绩可能受到负面影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618386011","title":"联邦制药(03933)发盈警 预期2025年溢利降至约20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618386011","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618386011?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:06","pubTimestamp":1773309969,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药(03933)公布，预期该集团于2025年取得溢利约20亿元，而2024年溢利约26.58亿元。溢利减少主要由于年内中间体产品及原料药的市场价格下跌，导致中间体产品及原料药的分部溢利与2024年比较，分别下降约16亿元及约4亿元。制剂产品分部溢利大幅上升约14亿元，其中来自诺和诺德股份有限公司的许可费收入贡献约13亿元，部分补偿了中间体产品及原料药分部的溢利下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"联邦制药(03933)发盈警 预期2025年溢利降至约20亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2619157905","title":"联邦制药：盈利警告","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157905","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619157905?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:03","pubTimestamp":1773309792,"startTime":"0","endTime":"0","summary":"联邦制药发布盈利警告，预计截至2025年12月31日止年度将录得溢利约人民币20亿元，较2024年度约人民币26.58亿元下降。溢利下滑主要由于年内中间体产品及原料药的市场价格下跌，导致这两个分部溢利分别减少约人民币16亿元及4亿元。然而，制剂产品分部表现亮眼，溢利大幅上升约人民币14亿元，其中来自诺和诺德的许可费收入贡献约人民币13亿元，部分抵消了其他分部的溢利下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312184952a6baabd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312184952a6baabd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2619157183","title":"每日卖空追踪 | 联邦制药 03月12日卖空量成交40万股，卖空比例为6.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619157183?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304237,"startTime":"0","endTime":"0","summary":"联邦制药北京时间03月12日，跌1.45%，卖空量成交40万股，较上一交易日减少58.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163532a46375d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163532a46375d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618926050","title":"每日卖空追踪 | 联邦制药 03月11日卖空量成交41.2万股，卖空比例为6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618926050","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618926050?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217836,"startTime":"0","endTime":"0","summary":"联邦制药北京时间03月11日，跌0.91%，卖空量成交41.2万股，较上一交易日减少70.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163520a460b7d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163520a460b7d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618620856","title":"联邦制药拟3月24日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620856","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620856?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:34","pubTimestamp":1773045291,"startTime":"0","endTime":"0","summary":"联邦制药(03933.HK)公告，董事会将于2026年3月24日(星期二)举行会议，其中包括考虑及批准公司及其附属公司截至2025年12月31日止年度全年业绩，及建议派发末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163521a45ae932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163521a45ae932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618178646","title":"联邦制药(03933)：德谷胰岛素注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2618178646","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618178646?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:33","pubTimestamp":1773045235,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，公司全资附属公司珠海联邦生物医药有限公司申报的德谷胰岛素注射液通过中国国家药品监督管理局药品上市注册审批，药品批准文号分别为：国药准字S20260015;国药准字 S20260016。德谷胰岛素是新一代超长效基础胰岛素类似物，用于成人糖尿病的治疗，可单独使用或与口服降糖药、餐时胰岛素联合用药，全面满足临床长期血糖管理需求。现时，德谷胰岛素已纳入国家医保目录乙类药品，可及性与经济性优势显着。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"联邦制药(03933)：德谷胰岛素注射液获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618862082","title":"每日卖空追踪 | 联邦制药 03月09日卖空量成交144.6万股，卖空比例为12.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618862082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618862082?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045036,"startTime":"0","endTime":"0","summary":"联邦制药北京时间03月09日，跌1.44%，卖空量成交144.6万股，较上一交易日减少42.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163523a6b1c8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163523a6b1c8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618986808","title":"联邦制药03月09日主力净流出131.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618986808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618986808?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044147,"startTime":"0","endTime":"0","summary":"03月09日, 联邦制药股价跌1.44%，报收13.01元，成交金额1.5亿元，换手率0.59%，振幅3.33%，量比0.85。联邦制药今日主力资金净流出131.9万元，上一交易日主力净流入2068.2万元。该股近5个交易日上涨2.18%，主力资金累计净流入2176.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入7473.8万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161925a6b1b70b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161925a6b1b70b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","02268","BK1141","BK1574","02228","LU2399975544.HKD","LU0540923850.HKD","LU2476274720.SGD","06160","BK1515","IE00B5MMRT66.SGD","LU0348783233.USD","03329","BK1593","LU0417516571.SGD","LU2488822045.USD","LU0348735423.USD","IE00BPRC5H50.USD","LU1961090484.USD","BK1197","LU1115378108.SGD","SG9999014674.SGD","09688","LU0640798160.USD","LU1719994722.HKD","01099","BK1207","LU0348784397.USD","LU2476274308.USD","LU0588546209.SGD","02367","BK1585","01530","LU0348827113.USD","LU0561508036.HKD","LU1770034418.SGD","SG9999004311.SGD","HK0000165453.HKD","BK1191","LU0348766576.USD","03933","02196","09939","LU2778985437.USD","09926","159938","LU1794554557.SGD","LU2328871848.SGD","LU0348825331.USD","LU1303224171.USD"],"gpt_icon":0},{"id":"2617282695","title":"每日卖空追踪 | 联邦制药 03月05日卖空量成交91.8万股，卖空比例为7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617282695","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617282695?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699436,"startTime":"0","endTime":"0","summary":"联邦制药北京时间03月05日，涨3.67%，卖空量成交91.8万股，较上一交易日减少78.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163520a6a5da81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163520a6a5da81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1171226602","title":"联邦制药（03933）2月无新增发行 股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1171226602","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171226602?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:03","pubTimestamp":1772615023,"startTime":"0","endTime":"0","summary":"联邦制药国际控股有限公司（股票代码：03933）于2026年3月4日发布的月报显示，截至2026年2月28日，公司注册股本维持3,800,000,000股，面值每股0.01港元，对应注册股本总额为38,000,000港元，较上月无任何增减变化。\n公司已发行股份总数为1,973,026,508股，库存股份为零，报告期内不存在新增发行、购回或注销股份等活动。公司同时确认已符合香港联交所适用的公众持股量要求，并遵守相关上市规则及法律法规。\n公告由公司秘书梁永康正式签署，公司股本结构及上市地位均保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2616322726","title":"联邦制药03月03日主力净流出213.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616322726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616322726?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:16","pubTimestamp":1772525771,"startTime":"0","endTime":"0","summary":"03月03日, 联邦制药股价跌2.33%，报收12.55元，成交金额1.6亿元，换手率0.65%，振幅6.69%，量比1.04。联邦制药今日主力资金净流出213.0万元，上一交易日主力净流入632.2万元。该股近5个交易日上涨3.94%，主力资金累计净流入3618.8万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6612.5万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162323a69c9ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162323a69c9ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2616235995","title":"每日卖空追踪 | 联邦制药 03月02日卖空量成交190万股，卖空比例为13.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616235995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616235995?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440239,"startTime":"0","endTime":"0","summary":"联邦制药北京时间03月02日，跌1.15%，卖空量成交190万股，较上一交易日减少42.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163611a730c984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163611a730c984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538865?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","BK1161","IE00B543WZ88.USD","06978","BK1585","LU0348783233.USD","01099","LU0307460666.USD","02367","LU0348784397.USD","HK0000165453.HKD","02196","LU1961090484.USD","SG9999014674.SGD","LU1969619763.USD","LU1720050803.USD","BK1141","03933","02268","BK1617","09926","159992","BK1100","BK1197","LU2328871848.SGD","LU2488822045.USD","LU2476274720.SGD","SG9999004311.SGD","IE00B5MMRT66.SGD","LU0588546209.SGD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0640798160.USD","06160","LU0348827113.USD","02228","09688","LU1251922891.USD","BK1207","BK1574","LU1303224171.USD","LU0561508036.HKD","01530","LU1794554557.SGD","01789","LU1115378108.SGD","BK1515","BK1583","LU0348735423.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009267?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","159938","SG9999014674.SGD","LU0417516902.SGD","BK1515","02268","LU0417516571.SGD","09939","01099","BK1100","LU0348784397.USD","LU0348767384.USD","LU2778985437.USD","LU1770034418.SGD","LU1251922891.USD","02367","LU2476274720.SGD","03329","LU2399975544.HKD","BK1147","BK1161","BK1588","IE00B543WZ88.USD","BK1207","LU0348825331.USD","03933","09688","01530","LU0417516738.SGD","LU0348827113.USD","LU1794554557.SGD","LU0348766576.USD","02196","LU2476274308.USD","BK1197","HK0000165453.HKD","LU0540923850.HKD","09926","BK1141","06160","LU0640798160.USD","BK1617","02228","BK1191","LU0588546209.SGD","01789","LU0634319403.HKD","LU2488822045.USD","LU1961090484.USD","LU1720050803.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1676},{"period":"3month","weight":-0.1582},{"period":"6month","weight":-0.3298},{"period":"1year","weight":-0.3382},{"period":"ytd","weight":-0.0958}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联邦制药国际控股有限公司是一家投资控股公司，主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.368421,"avgChangeRate":-0.033088},{"month":2,"riseRate":0.736842,"avgChangeRate":0.076003},{"month":3,"riseRate":0.631579,"avgChangeRate":0.028098},{"month":4,"riseRate":0.611111,"avgChangeRate":0.081119},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.011153}],"exchange":"SEHK","name":"联邦制药","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联邦制药,03933,联邦制药股票,联邦制药股票老虎,联邦制药股票老虎国际,联邦制药行情,联邦制药股票行情,联邦制药股价,联邦制药股市,联邦制药股票价格,联邦制药股票交易,联邦制药股票购买,联邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}